BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30856196)

  • 1. Relationship between Highly Active Antiretroviral Therapy (HAART) and human papillomavirus type 16 (HPV 16) infection among women in Sub-Saharan Africa and public health implications: A systematic review.
    Menon S; Rossi R; Kariisa M; Acharya SD; Zdraveska N; Mahmood S; Callens S; Ndizeye Z
    PLoS One; 2019; 14(3):e0213086. PubMed ID: 30856196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research.
    Menon S; Rossi R; Zdraveska N; Kariisa M; Acharya SD; Vanden Broeck D; Callens S
    BMJ Open; 2017 Aug; 7(8):e015123. PubMed ID: 28780541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the HPV vaccine schedule for a HIV-infected population in sub Saharan Africa, a commentary.
    Menon S; Rossi R; Kariisa M; Callens S
    Virol J; 2018 Aug; 15(1):129. PubMed ID: 30115083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
    Ndiaye C; Alemany L; Ndiaye N; Kamaté B; Diop Y; Odida M; Banjo K; Tous S; Klaustermeier JE; Clavero O; Castellsagué X; Bosch FX; Trottier H; de Sanjosé S
    Trop Med Int Health; 2012 Dec; 17(12):1432-40. PubMed ID: 23107344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection Among Sub-Saharan African Women: A Systematic Review and Meta-Analysis.
    Seyoum A; Assefa N; Gure T; Seyoum B; Mulu A; Mihret A
    Front Public Health; 2022; 10():890880. PubMed ID: 35875040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus prevalence among men in sub-Saharan Africa: a systematic review and meta-analysis.
    Olesen TB; Munk C; Christensen J; Andersen KK; Kjaer SK
    Sex Transm Infect; 2014 Sep; 90(6):455-62. PubMed ID: 24812407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.
    Mboumba Bouassa RS; Prazuck T; Lethu T; Jenabian MA; Meye JF; Bélec L
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):613-627. PubMed ID: 28440679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of high-risk HPV genotypes in sub-Saharan Africa according to HIV status: a 20-year systematic review.
    Okoye JO; Ofodile CA; Adeleke OK; Obioma O
    Epidemiol Health; 2021; 43():e2021039. PubMed ID: 34044477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.
    Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
    J Infect Dis; 2013 Jun; 207(11):1723-9. PubMed ID: 23463709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
    Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
    Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly active antiretroviral therapy (HAART) and outcome of cervical lesions and high-risk HPV in women living with HIV (WLHIV): A systematic review and meta-analysis.
    Gupta R; Mariano LC; Singh S; Gupta S
    Eur J Obstet Gynecol Reprod Biol; 2022 Nov; 278():153-158. PubMed ID: 36194939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of highly active antiretroviral therapy is associated with lower prevalence of anal intraepithelial neoplastic lesions and lower prevalence of human papillomavirus in HIV-infected men who have sex with men.
    van der Snoek EM; van der Ende ME; den Hollander JC; Schutten M; Neumann HA; van Doornum GJ
    Sex Transm Dis; 2012 Jul; 39(7):495-500. PubMed ID: 22695316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.
    Louie KS; de Sanjose S; Mayaud P
    Trop Med Int Health; 2009 Oct; 14(10):1287-302. PubMed ID: 19772550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa.
    Memiah P; Shumba C; Etienne-Mesubi M; Agbor S; Hossain MB; Komba P; Niyang M; Biadgilign S
    J Int Assoc Provid AIDS Care; 2014; 13(4):346-52. PubMed ID: 25513032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of HAART on HPV-related cervical disease.
    Adler DH
    Curr HIV Res; 2010 Oct; 8(7):493-7. PubMed ID: 20946095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus.
    Mboumba Bouassa RS; Prazuck T; Lethu T; Meye JF; Bélec L
    Med Sante Trop; 2017 Feb; 27(1):16-22. PubMed ID: 28406406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
    PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus antibody response following HAART initiation among MSM.
    Combes JD; Clifford GM; Egger M; Cavassini M; Hirsch HH; Hauser C; Calmy A; Schmid P; Bernasconi E; Günthard HF; Franceschi S; Waterboer T; Scherrer AU;
    AIDS; 2017 Feb; 31(4):561-569. PubMed ID: 28121669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
    Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.